Sumatriptan Succinate
Product Images NDC 45865-570

4 FDA label images from Medsource Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Sumatriptan Succinate (NDC 45865-570). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medsource Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (570 9)

Pdp (570 9)
Sumatriptan Succinate Tablets 25 mg label, generic for Imitrex, showing the product name prominently with dosage strength. The label includes dosage information, manufacturer details as Dr. Reddy's Laboratories/Bachem, batch group number #9, and warnings about dizziness, drowsiness, and alcohol avoidance in both English and Spanish. The label design uses black text on a white background with green borders and peelable patient information and log chart sections.*
FDA Label Image

Figure1 (Figure1)

Figure1 (Figure1)
A line graph titled 'Estimated Probability of Achieving Initial Headache Response Within 240 Minutes,' showing percentage response on the y-axis and time in minutes from initial dose on the x-axis. Four curves represent placebo, 25 mg, 50 mg, and 100 mg doses, highlighting higher response rates with increasing doses over time.*
FDA Label Image

Figure2 (Figure2)

Figure2 (Figure2)
A line graph showing the estimated probability over 24 hours of patients taking a second dose or other medication for migraine following the initial dose of study treatment with Sumatriptan Succinate. The graph compares placebo and three dosage levels of 25 mg, 50 mg, and 100 mg, with probability on the y-axis and time in hours on the x-axis.*
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of Sumatriptan Succinate, showing the molecular components and arrangement of the active ingredient.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.